ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing: NO.

Zoé LE van Kempen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.